Evidence map›Paper›PMID 21167936›Full record

ArticleFree radical biology & medicine2011

Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion.

Abigail Woodfin, De-En Hu, Mosharraf Sarker, Tsuyoshi Kurokawa, Paul Fraser

Open access · hybridAbstract read
In one paragraph

Article in Free radical biology & medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Normobaric Hyperoxia Therapy in Treating Stroke.Clinical interventions in aging · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Efficacy of prophylactic flavan-3-ol in permanent focal ischemia in 12-mo-old mice.American journal of physiology. Heart and circulatory physiology · 2015
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Abigail WoodfinBHF Centre of Research Excellence, Cardiovascular Division, King's College London, London SE1 9NH, UK.
De-En Hu
Mosharraf Sarker
Tsuyoshi Kurokawa
Paul Fraser
King's College London · GB

Funding

British Heart Foundation
6 · The paper itself

Abstract

Free radical generation is a key event in cerebral reperfusion injury. Bradykinin (Bk) and interleukin-1β (IL-1β) have both been implicated in edema formation after stroke, although acute Bk application itself results in only a modest permeability increase. We have investigated the molecular mechanism by assessing the permeability of single pial venules in a stroke model. Increased permeability on reperfusion was dependent on the duration of ischemia and was prevented by applying the B(2) receptor antagonist HOE 140. Postreperfusion permeability increases were mimicked by applying Bk (5μM) for 10 min and blocked by coapplying the IL-1 receptor antagonist with Bk. Furthermore, 10 min pretreatment with IL-1β resulted in a 3 orders of magnitude leftward shift of the acutely applied Bk concentration-response curve. The left shift was abolished by scavenging free radicals with superoxide dismutase and catalase. Apocynin coapplied with IL-1β completely blocked the potentiation, implying that NADPH oxidase assembly is the immediate target of IL-1β. In conclusion, this is first demonstration that bradykinin, released during cerebral ischemia, leads to IL-1β release, which in turn activates NADPH oxidase leading to blood-brain barrier breakdown.

Indexed as

AcetophenonesAnimalsBradykininBradykinin Receptor AntagonistsBrainBrain IschemiaCapillary PermeabilityCatalaseEnzyme ActivationFemaleFree Radical ScavengersInterleukin-1betaMaleMicrospheresNADPH OxidasesRatsAcetophenonesacetovanilloneBradykininBradykinin Receptor AntagonistsCatalaseFree Radical ScavengersicatibantInterleukin-1betaNADPH OxidasesReactive Oxygen SpeciesSuperoxide Dismutase

Identifiers

PMID21167936
PMCPMC3038265
OpenAlexW2007381306

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.